Development of INRASTES research activities in the framework of the National Research and Technology Strategy for Smart Specialization (MIS 5002559).
Novel optical biosensors based on Si nanowires for determining cancer, metabolic and oxidizing stress indicators
Development of immunochemical analytical methodology, especially an ELISA and a biosensor assay, for determining benzimidazole-type pesticides
Monolithically integrated interferometric biochips for label-free early detection of human diseases
FOOD Safety at the point-of-Need via monolithic spectroscopic chip identiFying harmFul substances in frEsh pRoduce
Rapid detection of harmful substances and adulteration of raw milk using immersible nanophotonic sensors
Development of an automated, novel biosensor platform for pesticide residue detection
Rapid, timely DIAgnosis and MONitoring of microbial infections by means of an automated, point-of-care, diagnostic system
GSTT1, GSTM1 and ΝQO1 gene polymorphisms in Greek patients with multiple sclerosis: Relevance as predisposing factors
Translating genomic and epigenetic studies of MDS and AML
Occupational and environmental exposures in MDS pathogenesis
Realizing the European Network in Biodosimetry
The use of cytogenetic and molecular endpoints as biomarkers of low dose radiation exposure in interventional cardiology
Development of cytogenetic assays for the assessment of individual radiosensitivity and evaluation of modern individualized radiotherapy techniques
Mechanistic insights on the aetiology of space radiation-induced chromosomal aberrations and risk for carcinogenesis using conventional and interphase cytogenetics
Rapid and minimally invasive early triage biodosimetry using Giemsa staining to score radiation-induced excess lymphocyte prematurely condensed chromosomes or Centromeric/Telomeric PNA probes to score accurately dicentrics and centric rings only in the over exposed individuals
Breast cancer stem cells resistance mechanisms in genotoxic insults: Applications in diagnosis, personalized treatment strategies and prognosis of disease progression
Molecular typing of triple negative breast cancer
Radiation Biodosimetry and Leukemia Cytogenetics
Identification of genetic biomarkers associated with endometriosis-related infertility and malignant transformation
Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe
Blue Bio Med
National Research Infrastructures Program
Genetic background investigation of mallignant diseases in children
Molecular Genetics Analysis of ovarian cancer
Investigation of hereditary predisposition in polyposis and colorectal cancer
Molecular Genetics Analysis in breast cancer
Hereditary Cancer predisposition, DNA homologous recombination mechanisms study
Molecular Genetics Analysis in women with gradeIII serous ovarian cancer in order to be eligible for receiving Olapararib as 2nd line Chemotherapy
Hellenic Precision Medicine Network on Cancer
